⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

June 18, 2024Pancreas

Combined Efficacy of Nimotuzumab and Gemcitabine on the Treatment of Advanced Pancreatic cancer

Yi Li Dan Li Qianqian Liu Jun Li

View Full Paper

Ask AI

Bookmark

Share

Abstract

We sought to investigate whether the addition of nimotuzumab to gemcitabine would improve the treatment efficacy of advanced pancreatic cancer.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Li et al. (2024) studied this question.

synapsesocial.com/papers/68e64524b6db6435875d6202 https://doi.org/10.1097/mpa.0000000000002328

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Nimotuzumab Plus Gemcitabine-based Adjuvant Chemotherapy for Resectable Pancreatic Cancer: A Retrospective Observational Study2025
2Efficacy of cadonilimab in combination with nimotuzumab and AG regimen in TMB-H/KRAS wild-type advanced pancreatic cancer: a case report2025 · 1 citations
3Efficacy and safety of neoadjuvant chemotherapy with AG regimen with or without nimotuzumab in borderline resectable or locally advanced pancreatic cancer: A retrospective cohort study.Cohort Study · 2026
4Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group TrialRCT · 2011 · 830 citations
5Successful treatment of GEMOX regimen combined with nimotuzumab in the pancreatic cancer with wild KRAS and mutant BRCA: a report of two cases2024 · 1 citations